Ana Stegic - Net Worth and Insider Trading

Ana Stegic Net Worth

The estimated net worth of Ana Stegic is at least $10,335 dollars as of 2024-09-21. Ana Stegic is the Senior Officer of Antibe Therapeutics Inc and owns about 35,033 shares of Antibe Therapeutics Inc (TSX:ATE) stock worth over $10,335. Details can be seen in Ana Stegic's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ana Stegic has not made any transactions after 2022-05-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Ana Stegic

To

Ana Stegic Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ana Stegic owns 1 companies in total, including Antibe Therapeutics Inc (TSX:ATE) .

Click here to see the complete history of Ana Stegic’s form 4 insider trades.

Insider Ownership Summary of Ana Stegic

Ticker Comapny Transaction Date Type of Owner
TSX:ATE Antibe Therapeutics Inc 2022-05-06 Senior Officer

Ana Stegic Latest Holdings Summary

Ana Stegic currently owns a total of 1 stock. Ana Stegic owns 35,033 shares of Antibe Therapeutics Inc (TSX:ATE) as of May 6, 2022, with a value of $10,335.

Latest Holdings of Ana Stegic

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:ATE Antibe Therapeutics Inc 2022-05-06 35,033 0.30 10,335

Holding Weightings of Ana Stegic


Ana Stegic Form 4 Trading Tracker

According to the SEC Form 4 filings, Ana Stegic has made a total of 3 transactions in Antibe Therapeutics Inc (TSX:ATE) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Antibe Therapeutics Inc is the acquisition of 28,500 shares on May 6, 2022, which cost Ana Stegic around $19,950.

Insider Trading History of Ana Stegic

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ana Stegic Trading Performance

GuruFocus tracks the stock performance after each of Ana Stegic's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ana Stegic is -23.27%. GuruFocus also compares Ana Stegic's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ana Stegic within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ana Stegic's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ana Stegic

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -19.68 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -18.21 LIMIT LIMIT LIMIT LIMIT LIMIT

Ana Stegic Ownership Network

Ownership Network List of Ana Stegic

No Data

Ownership Network Relation of Ana Stegic

Insider Network Chart

Ana Stegic Owned Company Details

What does Antibe Therapeutics Inc do?

Who are the key executives at Antibe Therapeutics Inc?

Ana Stegic is the Senior Officer of Antibe Therapeutics Inc. Other key executives at Antibe Therapeutics Inc include Director & Director or Senior Officer of 10% Security Holder & Senior Officer John Lawrence Wallace , Senior Officer Joseph Stauffer , and Senior Officer Scott Wilson Curtis .

Antibe Therapeutics Inc (TSX:ATE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Antibe Therapeutics Inc (TSX:ATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antibe Therapeutics Inc (TSX:ATE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antibe Therapeutics Inc (TSX:ATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Antibe Therapeutics Inc Insider Transactions

No Available Data

Ana Stegic Mailing Address

Above is the net worth, insider trading, and ownership report for Ana Stegic. Currently GuruFocus does not have mailing address information for Ana Stegic.

Discussions on Ana Stegic

No discussions yet.